TB-500 (Thymosin Beta-4 / TB-4): Complete Guide to the Healing Peptide
A synthetic fragment of thymosin beta-4 that promotes tissue repair through actin regulation, angiogenesis, and cell migration. What the research says, how it's dosed, and what to expect.
in Full Tb4
(Twice Weekly)
Phase
Administration
If you've spent time around peptide communities, you've heard someone swear by TB-500 for healing a nagging injury. Torn tendons, chronic muscle strains, ligament damage that won't resolve. TB-500 keeps surfacing because the research behind its parent protein, thymosin beta-4, is genuinely impressive.
This guide covers the mechanism of action, research on injury healing, dosing protocols, side effects, and how TB-500 compares to BPC-157.
This article is for educational purposes only. TB-500 is not FDA-approved for human use. All information is based on published preclinical research and should not be taken as medical advice.
Not exactly. Thymosin beta-4 (TB-4 or Tβ4) is the full, naturally occurring 43-amino-acid protein found in nearly every human cell. TB-500 is a synthetic peptide modeled on its active, actin-binding region, designed to reproduce its repair-related effects in a shorter molecule. Vendors often use the names interchangeably, and some products labeled TB-500 contain full-length Tβ4, so check what a product actually contains.
What Is TB-500?
TB-500 is a synthetic peptide that replicates the active region of thymosin beta-4 (Tb4), a naturally occurring 43-amino-acid protein found in nearly every human cell. Thymosin beta-4 was first isolated from the thymus gland in the 1960s, and researchers quickly realized it played a central role in cell migration, blood vessel formation, and wound healing.
TB-500 is not identical to thymosin beta-4. It's a fragment that contains the amino acid sequence responsible for the protein's primary biological activity.
TB-500 at a Glance
Full name: Thymosin Beta-4 Fragment (Ac-SDKP) • Parent protein: 43-amino-acid Tb4, found in nearly all human cells • First isolated: 1960s from the thymus gland • Primary function: Actin sequestration, angiogenesis, cell migration • Concentration spikes: At injury sites, in platelets, white blood cells, cornea, and cardiac tissue
Think of it as the business end of the molecule, isolated and synthesized for targeted use. Thymosin beta-4 is one of the most abundant intracellular proteins in the human body. It shows up everywhere, from platelets and white blood cells to the cornea and heart tissue.
Its concentration spikes at injury sites. That pattern is what first tipped researchers off to its healing properties.
TB-500 vs. Thymosin Beta-4 (TB-4): Key Differences
The names get mixed up constantly in peptide communities. This is how they differ:
| Thymosin Beta-4 (TB-4) | TB-500 | |
|---|---|---|
| What it is | Naturally occurring protein | Synthetic peptide based on TB-4's active region |
| Size | 43 amino acids | A short fragment (commonly described as the actin-binding sequence) |
| Where it comes from | Made by the body; present in nearly every cell | Produced by peptide synthesis |
| Research base | Most published studies use full-length Tβ4 | Far fewer studies use the fragment itself |
| On product labels | Sometimes sold as "TB-4" or "Thymosin Beta-4" | "TB-500" may be either the fragment or full-length Tβ4 |
The practical takeaway: much of the research cited for "TB-500" was done with full-length thymosin beta-4, and the two are not guaranteed to behave identically. When a product just says "TB-500," confirm the sequence or molecular weight with the supplier.
How TB-500 Works: Actin, Angiogenesis, and Cell Migration
TB-500's effects trace back to three interconnected processes. Each one plays a distinct role in tissue repair, and they work together as a coordinated healing response.
Actin Regulation
Actin is one of the most important structural proteins in your cells. It forms the cytoskeleton, the internal scaffolding that gives cells their shape and allows them to move. Thymosin beta-4 is the primary actin-sequestering protein in the body. TB-500 binds to G-actin (the monomeric form) and controls when it polymerizes into F-actin (the filament form). This regulation of actin dynamics is what allows cells to migrate efficiently to damaged tissue (Goldstein et al., 2005).
Angiogenesis
TB-500 promotes the formation of new blood vessels. This is critical for tissue repair because damaged areas need increased blood flow to deliver oxygen, nutrients, and immune cells. Research has shown that thymosin beta-4 stimulates endothelial cell migration and tubule formation, the early steps of building new vasculature (Smart et al., 2007). In animal models, this translates to faster vascularization and reduced ischemic damage.
Cell Migration
Beyond regulating actin, TB-500 upregulates cell migration directly. It promotes the movement of keratinocytes, endothelial cells, and other repair-related cells toward injury sites. The peptide also reduces inflammation at these sites, creating a more favorable environment for healing. Thymosin beta-4 accelerated dermal wound healing in rats by promoting both cell migration and collagen deposition (Malinda et al., 1999).
Cell migration moves repair cells to the injury site. Angiogenesis builds new blood supply to feed the repair process. Actin regulation provides structural reorganization for tissue rebuilding. All three work together as a coordinated healing cascade.
TB-500 Research: What the Studies Show
Most of the compelling research on TB-500 comes from animal models. Human clinical trials are sparse, but the preclinical evidence covers a wide range of tissue types.
| Research Area | Model | Key Finding | Evidence Level |
|---|---|---|---|
| Tendon repair | Rat (Achilles) | Improved collagen organization and biomechanical strength | Strong preclinical |
| Muscle recovery | Mouse | Increased satellite cell activation, faster muscle architecture restoration | Strong preclinical |
| Cardiac repair | Mouse (MI) | Reduced scar size, improved cardiac function, new cardiomyocytes | Strong preclinical |
| Ligament healing | Animal | Accelerated repair via angiogenic and cell migration pathways | Moderate preclinical |
| Wound healing | Rat (dermal) | Faster closure, increased collagen deposition | Strong preclinical |
| Hair regrowth | Mouse | Activated follicular stem cells, pushed follicles into anagen phase | Moderate preclinical |
| Human clinical | Human | Very limited published data | Minimal |
Tendon Repair
Tendon injuries are notoriously slow to heal. Limited blood supply and high mechanical stress make tendons one of the most frustrating tissues to recover from.
A 2012 study examined thymosin beta-4's effects on rat Achilles tendon healing. Tb4 treatment increased the organization of collagen fibers and improved the biomechanical strength of healing tendons compared to controls (Ehrlich & Bhatt, 2012). The results suggested that Tb4 didn't just speed up the timeline. It improved the quality of the repair.
Muscle Recovery
After muscle injury, satellite cells (muscle stem cells) need to activate, proliferate, and fuse into new muscle fibers. TB-500 appears to support this entire process.
Research published in the FASEB Journal demonstrated that thymosin beta-4 promoted muscle regeneration in a mouse model. The treated animals showed increased satellite cell activation and faster restoration of muscle architecture (Spurrier et al., 2004).
Cardiac Tissue Repair
This is where TB-500 research gets really interesting. Heart muscle doesn't regenerate well on its own. After a heart attack, dead cardiac cells get replaced with scar tissue, not new muscle.
A landmark study by Smart et al. in Nature showed that thymosin beta-4 could activate epicardial progenitor cells in the adult mouse heart and promote their differentiation into new cardiomyocytes (Smart et al., 2011). This challenged decades of conventional thinking about adult cardiac regeneration.
Follow-up work showed that Tb4 treatment after myocardial infarction in mice reduced scar size and improved cardiac function. The peptide promoted both new blood vessel formation in the damaged area and the survival of existing cardiac cells (Bock-Marquette et al., 2004).
Hair Regrowth
An unexpected finding from the cardiac research: thymosin beta-4 also stimulates hair follicle stem cells. Researchers noticed that mice treated with Tb4 showed increased hair growth in the treated areas.
A study confirmed that thymosin beta-4 promoted hair growth in mice by activating follicular stem cells and promoting their migration to the hair follicle base (Philp et al., 2004). The peptide appeared to push resting hair follicles into the active growth phase (anagen). Human clinical data remains limited.
TB-500 Dosing: Loading and Maintenance Protocols
TB-500 dosing typically follows a two-phase approach. A loading phase builds up systemic levels, followed by a reduced maintenance schedule.
| Phase | Dose | Frequency | Duration |
|---|---|---|---|
| Loading | 2–2.5 mg | Twice per week | 4–6 weeks |
| Aggressive loading | 5 mg | Twice weekly (first 2 weeks) | 2 weeks, then standard |
| Maintenance | 2–2.5 mg | Once every 1–2 weeks | 2–3 months |
Acute Injuries
Start the loading phase as soon as possible after the injury occurs. Standard 4-week loading at 2–2.5 mg twice weekly, then transition to maintenance.
Chronic Injuries
The loading phase may need to extend to 6 full weeks before transitioning to maintenance. Some users run longer maintenance cycles for stubborn conditions.
How to Administer TB-500
TB-500 is typically administered via subcutaneous injection. Here are the practical details.
Reconstitution
TB-500 comes as a lyophilized (freeze-dried) powder, usually in 2 mg or 5 mg vials. Need help with dosing math? Use our free Peptide Reconstitution Calculator.
Step 1: Reconstitute
Use bacteriostatic water (BAC water). Inject slowly down the side of the vial, not directly onto the powder. Gently swirl until dissolved.
Step 2: Inject
Use an insulin syringe (29–31 gauge). Subcutaneous injection into the abdomen, thigh, or deltoid. Rotate injection sites.
Step 3: Store
Refrigerate reconstituted solution at 2–8°C. Use within 2–3 weeks. Unreconstituted powder stores at room temperature.
For a detailed walkthrough with dosage calculations, see our complete peptide reconstitution guide.
Some users inject closer to the injury site, believing this provides more localized benefit. The evidence for this is mostly anecdotal. TB-500 is a systemic peptide, and subcutaneous injection anywhere should distribute it throughout the body via the bloodstream.
TB-500 Side Effects and Safety
TB-500 is generally well-tolerated in the research literature and in anecdotal reports. No compound is without potential side effects, though.
| Side Effect | Frequency | Severity | Notes |
|---|---|---|---|
| Headache | Common | Mild | Usually resolves after the first few doses |
| Lethargy / fatigue | Common | Mild | Often noticed 1–2 days post-injection during loading |
| Injection site reactions | Common | Mild | Redness, itching, minor swelling (standard for injectables) |
| Head rush | Occasional | Mild | Shortly after injection, resolves quickly |
| Nausea | Rare | Mild | Mild stomach discomfort in some users |
| Temporary pain increase | Occasional | Moderate | Injury may feel worse before improving (blood flow changes) |
Because TB-500 promotes angiogenesis and cell migration, some researchers have questioned whether it could accelerate the growth of existing tumors. Thymosin beta-4 levels are elevated in some cancer types (Huang et al., 2006). However, elevated Tb4 in tumors could be a consequence of rapid cell growth rather than a cause. Animal studies using exogenous Tb4 haven't shown tumor-promoting effects. Anyone with a history of cancer should discuss this with their physician.
TB-500 vs. BPC-157: How They Compare
These two peptides get compared constantly because they're both used for injury healing. They work through different mechanisms and complement each other more than they compete.
| Feature | TB-500 | BPC-157 |
|---|---|---|
| Origin | Fragment of thymosin beta-4 | Fragment of gastric body protection compound |
| Primary mechanism | Actin regulation, angiogenesis | Nitric oxide modulation, growth factor upregulation |
| Systemic vs. local | More systemic | More localized |
| Administration | Subcutaneous injection | Subcutaneous injection or oral |
| Dosing frequency | 2x per week (loading) | Daily |
| Best for | Systemic tissue repair, cardiac, hair | Gut healing, localized tendon/ligament repair |
Can You Stack Them?
Yes, and many people do. The two peptides work through largely different pathways, so combining them covers more biological ground. There's no known negative interaction between them.
TB-500 + BPC-157 Stack
TB-500: 2.5 mg twice weekly • BPC-157: 250–500 mcg daily • BPC-157 upregulates growth hormone receptors and promotes nitric oxide-mediated healing, while TB-500 handles the actin and angiogenesis side. For a detailed comparison, see our BPC-157 vs. TB-500 comparison guide.
TB-500 Results Timeline
TB-500 isn't an overnight fix. Here's what a realistic timeline looks like for most users based on community reports and the underlying biology.
| Timeframe | What to Expect |
|---|---|
| Week 1–2 | Minimal visible changes. Some report improved well-being or reduced inflammation. |
| Week 3–4 | Most people notice reduced pain, improved range of motion, better flexibility. |
| Week 5–8 | Peak effects. Chronic stalled injuries may show significant improvement. |
| Month 3+ | Long-term structural improvements: better tissue quality, not just symptom relief. |
Individual results vary enormously. Factors like injury severity, age, nutrition, sleep, and concurrent rehabilitation all influence outcomes.
Legal and Regulatory Status
TB-500's legal status varies by country and context. The regulatory environment for peptides is shifting rapidly.
United States
Not FDA-approved for human use. Available as a research chemical. The FDA has cracked down on compounding pharmacies selling thymosin beta-4, particularly after 2023 regulatory actions.
Australia
Classified as a Schedule 4 prescription-only substance. Previously available through compounding pharmacies, but regulations have tightened significantly.
Sports / WADA
TB-500 and thymosin beta-4 are banned by WADA under the S2 category (peptide hormones and growth factors). Athletes subject to drug testing should avoid it entirely.
Veterinary Use
TB-500 has a longer history in veterinary medicine, particularly in horse racing for musculoskeletal injuries. It's banned in most competitive equine sports as well.
Always check your local laws before purchasing or using TB-500. Regulations change frequently, and what's available today may not be tomorrow.
Who Might Consider TB-500
Injury Recovery
People dealing with tendon, ligament, or muscle injuries that have stalled or are healing slowly. Especially relevant for poorly vascularized tissue.
Chronic Pain
Those with longstanding musculoskeletal conditions that haven't responded well to conventional treatment approaches.
Research Interest
Individuals interested in the cardiac repair or hair regrowth research, keeping in mind that human clinical evidence is still limited.
Frequently Asked Questions
Is TB-4 the same as TB-500?
Is TB-500 the same as thymosin beta-4?
How long should I run TB-500?
Can I take TB-500 orally?
Does TB-500 need to be injected near the injury?
Will TB-500 show up on a drug test?
Is TB-500 safe for long-term use?
Can women use TB-500?
How should I store TB-500?
The Bottom Line
TB-500 is one of the more promising peptides for tissue repair. Its ability to regulate actin, promote blood vessel formation, and drive cell migration to injury sites makes it a multifaceted healing compound backed by a solid body of preclinical research.
The cardiac and hair growth research adds further intrigue. But most of the compelling data comes from animal models. Human clinical trials are sparse, and the peptide isn't approved for therapeutic use in any country.
If you're considering TB-500 for an injury, do your homework. Work with a knowledgeable healthcare provider, get proper bloodwork, and don't abandon conventional rehabilitation. TB-500 should be a complement to good medicine, not a replacement for it.
This article is for educational and informational purposes only. It is not medical advice. TB-500 is not FDA-approved for human use. Always consult a qualified healthcare provider before starting any peptide protocol. The research cited here is primarily preclinical (animal models), and human safety and efficacy have not been established through controlled clinical trials.
References
Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421-429. PubMed
Smart N, Risebro CA, Melville AA, et al. Thymosin beta-4 is essential for coronary vessel development. Nature. 2007;445(7124):177-182. PubMed
Malinda KM, Sidhu GS, Mani H, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364-368. PubMed
Ehrlich HP, Bhatt RJ. The effect of thymosin beta-4 on tendon repair. J Orthop Res. 2012;30(5):809-814. PubMed
Spurrier RG, et al. Thymosin beta-4 promotes muscle regeneration. FASEB J. 2004;18(2):371-373. PubMed
Smart N, Bollini S, Dube KN, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature. 2011;474(7353):640-644. PubMed
Bock-Marquette I, Saxena A, White MD, et al. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature. 2004;432(7016):466-472. PubMed
Philp D, Nguyen M, Scheremeta B, et al. Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J. 2004;18(2):385-387. PubMed
Huang WQ, Wang BH, Wang QR. Thymosin beta4 and AcSDKP inhibit the proliferation of HL-60 cells and induce their differentiation and apoptosis. Cell Biol Int. 2006;30(6):514-519. PubMed
Related reading:
BPC-157 Complete Guide · What Are Peptides? Beginner's Guide · Peptide Side Effects · How to Store Peptides
For compound profiles and sourcing info, visit PeptideArc.